Interpersonal Psychotherapy With Expressive Art for Depression in a Psycho-Oncology Context

2018 ◽  
Vol 17 (6) ◽  
pp. 453-468
Author(s):  
Jesse D. Bourke ◽  
Camille Plant ◽  
Sophia Wooldridge
Keyword(s):  
Clinical Symptoms ◽  
Interpersonal Psychotherapy ◽  
Problem Area ◽  
Theoretical Research ◽  
Self Reflection ◽  
Symptoms Of Depression ◽  
History Of ◽  
Creative Self ◽  
Major Depressive Episodes ◽  
Depressive Episodes

The following case outlines the use of interpersonal psychotherapy (IPT) with integrated expressive art practices over 10 sessions in treatment of AF, a 62-year-old Caucasian female presenting with depression as a psycho-oncology outpatient. AF’s presentation was in the context of a history of diagnosis and treatment of melanoma, several family losses to cancer, long-standing dysthymia and recurrent major depressive episodes, and relocation from interstate following marriage separation. IPT was delivered to address AF’s identified core problem area of interpersonal sensitivities, while expressive art exercises played a role of creative self-reflection and exploration. At the conclusion of therapy, AF demonstrated not only elimination of clinical symptoms of depression and anxiety but also growth as a newly resilient and enlivened individual. Theoretical, research, and intervention implications for treatment of depression in broad and specific to psycho-oncology contexts are discussed.

Effects of In Utero Exposure to AEDs on Morphology and Neurodevelopment

CNS Spectrums ◽  
2006 ◽  
Vol 11 (S5) ◽  
pp. 9-10
Author(s):  
Martha J. Morrell
Keyword(s):  
Bipolar Disorder ◽  
Clinical Information ◽  
Mood Stabilizer ◽  
Mood Stabilizers ◽  
Antipsychotic Treatment ◽  
Close Monitoring ◽  
History Of ◽  
Major Congenital Malformations ◽  
Major Depressive Episodes ◽  
Depressive Episodes

AbstractThe presentations and clinical courses of patients with bipolar disorder differ greatly by gender. In addition, medical therapy must be tailored differently for men and women because of emerging safety concerns unique to the female reproductive system. In November 2005, these topics were explored by a panel of experts in psychiatry, neurology, and reproductive health at a closed roundtable meeting in Dallas, Texas. This clinical information monograph summarizes the highlights of that meeting.Compared to men with bipolar disorder, women have more pervasive depressive symptoms and experience more major depressive episodes. They are also at higher risk for obesity and certain other medical and psychiatric comorbidities. Mood changes across the menstrual cycle are common, although the severity, timing, and type of changes are variable. Bipolar disorder is frequently associated with menstrual abnormalities and ovarian dysfunction, including polycystic ovarian syndrome. Although some cases of menstrual disturbance precede the treatment of bipolar disorder, it is possible that valproate and/or antipsychotic treatment may play a contributory role in young women.Pregnancy does not protect against mood episodes in untreated women. Maintenance of euthymia during pregnancy is critical because relapse during this period strongly predicts a difficult postpartum course. Suspending therapy in the first months of pregnancy may be an option for some women with mild-to-moderate illness, or those with a long history of euthymia during pre-pregnancy treatment. However, a mood stabilizer should be reintroduced either in the later stages of pregnancy or in the immediate postpartum period. Preliminary data suggest that fetal exposure to some mood stabilizers may raise the risk of major congenital malformations and neurodevelopmental delays. For women planning to become pregnant, clinicians may consider switching to other drugs before conception. The value and drawbacks of breastfeeding during treatment must be considered in partnership with the patient, with close monitoring of nursing infants thereafter. The risks and benefits of medical treatment for women with bipolar disorder should be carefully reconsidered at each stage of their reproductive lives, with a flexible approach that is responsive to the changing needs of patients and their families.

scholarly journals The necessity of knowledge of self for proper comprehension of divine knowledge in Mulla Sadra's view

2018 ◽  
Vol 2 (126) ◽  
pp. 73-84
Author(s):  
Rezvaneh Najafi Savad Roodbari
Keyword(s):  
Intuitive Knowledge ◽  
Self Reflection ◽  
Knowledge Of God ◽  
Presence Of God ◽  
Divine Knowledge ◽  
History Of ◽  
Self Knowledge ◽  
Creative Self ◽  
Active Intellect ◽  
Comprehensive Study

One of the ways to know God is to acquire self-knowledge. This kind of knowledge is intuitive and in complete harmony with the soul of the mystic because it arises from the depth of our being. This kind of knowledge of God is as old as the history of mankind. There are different versions of the give and take between these two kinds of knowledge, the introduction to most of which is a comprehensive study of self and being. This paper, in an analytical way, seeks to explain the threefold narrations contained in Mulla Sadra's books. 1. Intuiting God through the intuition of the soul and the intuition of the truths of the creatures that are embodied in the active intellect. 2. Intuiting God through the connection and association of the soul with its powers and actions, and paving the process from the creative self to God as the ultimate creator, 3. Intuiting God through man's position as a caliphate and that the caliphate is a sign of the believer. This kind of self-reflection has two consequences: intuitive knowledge of the presence of God and the limited knowledge of the existence and qualities of God, not his essence. Summarizing Mulla Sadra's narrations in relation to knowing God through self-knowledge and associating Sadra's analysis and interpretations with the knowledge of the presence of God are the main findings of the present study.

Who Becomes a Depressive Ruminator? Developmental Antecedents of Ruminative Response Style

2002 ◽  
Vol 16 (4) ◽  
pp. 405-419 ◽  
Author(s):  
Jelena Spasojević ◽  
Lauren B. Alloy
Keyword(s):  
College Freshmen ◽  
Response Style ◽  
Major Depressive ◽  
History Of Childhood ◽  
Developmental Factors ◽  
History Of ◽  
Developmental Antecedents ◽  
Major Depressive Episodes ◽  
Depressive Episodes

Developmental antecedents of ruminative response style were examined in 137 college freshmen, who were followed prospectively for 2.5 years. Reports of mothers’ and fathers’ psychologically overcontrolling parenting as well as a history of childhood sexual (for women only) and emotional maltreatment were all related to ruminative response style. In addition, ruminative response style mediated the relationships between these developmental factors and the number of major depressive episodes experienced by participants during the follow-up period. Potential explanations and important implications of these findings are discussed.

Core Beliefs and History of Major Depressive Episodes in Currently Non-depressed University Students

2008 ◽  
Vol 33 (1) ◽  
pp. 50-58 ◽  
Author(s):  
John R. Z. Abela ◽  
Randy P. Auerbach ◽  
Sabina Sarin ◽  
Zia Lakdawalla
Keyword(s):  
University Students ◽  
Core Beliefs ◽  
Major Depressive ◽  
History Of ◽  
Major Depressive Episodes ◽  
Depressive Episodes

Treatment of Bipolar Disorder During Pregnancy

CNS Spectrums ◽  
2006 ◽  
Vol 11 (S5) ◽  
pp. 11-12
Author(s):  
Lee S. Cohen
Keyword(s):  
Bipolar Disorder ◽  
Clinical Information ◽  
Mood Stabilizer ◽  
Mood Stabilizers ◽  
Antipsychotic Treatment ◽  
Close Monitoring ◽  
History Of ◽  
Major Congenital Malformations ◽  
Major Depressive Episodes ◽  
Depressive Episodes

AbstractThe presentations and clinical courses of patients with bipolar disorder differ greatly by gender. In addition, medical therapy must be tailored differently for men and women because of emerging safety concerns unique to the female reproductive system. In November 2005, these topics were explored by a panel of experts in psychiatry, neurology, and reproductive health at a closed roundtable meeting in Dallas, Texas. This clinical information monograph summarizes the highlights of that meeting.Compared to men with bipolar disorder, women have more pervasive depressive symptoms and experience more major depressive episodes. They are also at higher risk for obesity and certain other medical and psychiatric comorbidities. Mood changes across the menstrual cycle are common, although the severity, timing, and type of changes are variable. Bipolar disorder is frequently associated with menstrual abnormalities and ovarian dysfunction, including polycystic ovarian syndrome. Although some cases of menstrual disturbance precede the treatment of bipolar disorder, it is possible that valproate and/or antipsychotic treatment may play a contributory role in young women.Pregnancy does not protect against mood episodes in untreated women. Maintenance of euthymia during pregnancy is critical because relapse during this period strongly predicts a difficult postpartum course. Suspending therapy in the first months of pregnancy may be an option for some women with mild-to-moderate illness, or those with a long history of euthymia during pre-pregnancy treatment. However, a mood stabilizer should be reintroduced either in the later stages of pregnancy or in the immediate postpartum period. Preliminary data suggest that fetal exposure to some mood stabilizers may raise the risk of major congenital malformations and neurodevelopmental delays. For women planning to become pregnant, clinicians may consider switching to other drugs before conception. The value and drawbacks of breastfeeding during treatment must be considered in partnership with the patient, with close monitoring of nursing infants thereafter. The risks and benefits of medical treatment for women with bipolar disorder should be carefully reconsidered at each stage of their reproductive lives, with a flexible approach that is responsive to the changing needs of patients and their families.

scholarly journals Sensitivity and concurrent validity of the Japanese version of the Euthymia scale: a clinimetric analysis

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Natsu Sasaki ◽  
Danilo Carrozzino ◽  
Daisuke Nishi
Keyword(s):  
Psychological Distress ◽  
Concurrent Validity ◽  
Online Survey ◽  
Past History ◽  
Negative Relationship ◽  
Japanese Version ◽  
Well Being ◽  
History Of ◽  
Major Depressive Episodes ◽  
Depressive Episodes

Abstract Background Euthymia is characterized by the lack of mood disorders, the presence of positive affects, psychological flexibility and well-being, a unifying outlook on life, and resistance to stress. The Euthymia Scale (ES) is a 10-item self-rating clinimetric index assessing euthymia. Objectives The present study was conducted to examine the clinimetric sensitivity and concurrent validity of the Japanese version of the Euthymia Scale (ES-J). Methods A cross-sectional online survey was conducted. The Mini-International Neuropsychiatric Interview was used to determine the presence of past or current major depressive episodes (MDE). The clinimetric sensitivity was evaluated using the Analysis of Variance (ANOVA). Pearson’s correlation coefficients were performed to examine the concurrent validity of the ES-J. Results A total of 1030 eligible participants completed the survey. The ES-J differentiated healthy subjects from complete remission (i.e., those with a past history of MDE without current MDE) (p < 0.001), from those with past or current history of MDE (p < 0.001), subjects with current MDE from those with sub-threshold symptoms of depression (p < 0.001), and healthy participants from subjects with moderate to severe symptoms of psychological distress (p < 0.001). The associations between the ES-J and measures of psychological well-being, resilience, life satisfaction, and social support were significantly positive (0.353 < r < 0.666, p < 0.001). A negative relationship between the ES-J and measures of psychological distress was also found (r = − 0.595, p < 0.001). Conclusions The findings of the present study indicated that the ES-J is a valid and highly sensitive clinimetric index, which can be used as a screening measure in the clinical process of assessment of recovery, particularly when symptoms are expected to be mild and/or when dealing with subclinical symptoms of psychological distress and depression. The findings of this study also support the use of the ES-J to detect vulnerability to depression and to identify subjects at higher risk of relapse.

scholarly journals Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes

2000 ◽  
Vol 177 (4) ◽  
pp. 331-335 ◽  
Author(s):  
Toshiaki A. Furukawa ◽  
Toshinori Kitamura ◽  
Kiyohisa Takahashi
Keyword(s):  
Major Depression ◽  
Mood Disorder ◽  
Tertiary Care ◽  
Inception Cohort ◽  
Major Depressive ◽  
Follow Up Study ◽  
History Of ◽  
Major Depressive Episodes ◽  
Depressive Episodes

BackgroundGeneralisability of existing studies on the naturalistic history of major depression is undermined by overrepresentation of in-patients and tertiary care academic centres, inclusion of patients already on treatment and/or incomplete follow-up.AimsTo report the time to recovery of an inception cohort of unipolar major depressive episodes.MethodA multi-centre prospective follow-up study of patients with a mood disorder, who had been selected to be representative of the untreated first-visit patients at 23 psychiatric settings from all over Japan.ResultsThe median time to recovery of the index episode after treatment commencement was 3 months (95% CI 2.5–3.6): 26% of the cohort reached asymptomatic or minimally symptomatic status by I month, 63% by 3 months, 85% by 12 months and 88% by 24 months.ConclusionsOur estimate of the episode length was 25–50% shorter than estimates reported in the literature.

scholarly journals Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions

2009 ◽  
Vol 40 (3) ◽  
pp. 441-449 ◽  
Author(s):  
L. D. Torres ◽  
A. Z. Barrera ◽  
K. Delucchi ◽  
C. Penilla ◽  
E. J. Pérez-Stable ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Major Depressive ◽  
Quit Attempt ◽  
Quitting Smoking ◽  
History Of ◽  
English Speaking ◽  
Major Depressive Episodes ◽  
Depressive Episodes ◽  
Depression History ◽  
History Of Depression

BackgroundLimited evidence has suggested that quitting smoking increases the incidence of major depressive episodes (MDEs), particularly for smokers with a history of depression. Further evidence for this increase would have important implications for guiding smoking cessation.MethodSpanish- and English-speaking smokers without a current MDE (n=3056) from an international, online smoking cessation trial were assessed for abstinence 1 month after their initial quit date and followed for a total of 12 months. Incidence of screened MDE was examined as a function of abstinence and depression history.ResultsContinued smoking, not abstinence, predicted MDE screened at 1 month [smoking 11.5% v. abstinence 7.8%, odds ratio (OR) 1.36, 95% confidence interval (CI) 1.04–1.78, p=0.02] but not afterwards (smoking 11.1% v. abstinence 9.8%, OR 1.05, 95% CI 0.77–1.45, p=0.74). Depression history predicted MDE screened at 1 month (history 17.1% v. no history 8.6%, OR 1.71, 95% CI 1.29–2.27, p<0.001) and afterwards (history 21.7% v. no history 8.3%, OR 3.87, 95% CI 2.25–6.65, p<0.001), although the interaction between history and abstinence did not.ConclusionsQuitting smoking was not associated with increased MDE, even for smokers with a history of depression, although a history of depression was. Instead, not quitting was associated with increased MDE shortly following a quit attempt. Results from this online, large, international sample of smokers converge with similar findings from smaller, clinic-based samples, suggesting that in general, quitting smoking does not increase the incidence of MDEs.

Sign in / Sign up

Export Citation Format

Share Document